Manufacturing process study of Chimeric antigen receptor-T (CAR-T) cell therapy for solid cancer using healthy volunteer's samples
Not Applicable
- Conditions
- solid tumor
- Registration Number
- JPRN-UMIN000035998
- Lead Sponsor
- Kitasato University Kitasato Institute Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Subject who are entering or no more than 4 months after entered, or scheduled to enter other clinical research Subject who were drawn blood more than 1200 mL within a year Subject who donated whole blood more than 400mL within 12 weeks of IC Subject who donated whole blood more than 200mL within 4 weeks of IC Subject who donated whole blood component within 2 weeks of IC White blood cell < 4000/uL at screening
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method one
- Secondary Outcome Measures
Name Time Method